Intelligence Platform
Patents
Browse 14,889 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6329368
Endocrine modulation with positive modulators of AMPA type glutamate receptors
expired patentUS 6329349
Methods for reducing ischemic injury of the heart via the sequential administration of mon
expired patentUS 6329170
Nucleic acids and proteins of a rat ganglioside GM1-specific .alpha.1.fwdarw.2fucosyltrans
expired patentUS 6326361
Gangliosides with immunosuppressive activity
expired patentUS 6326356
Suppression of neu overexpression using a mini-E1A gene
expired patentUS 6326009
Enhancement of the cellular immune response
expired patentUS 6326198
Methods and compositions for the ex vivo replication of stem cells, for the optimization o
expired patentUS 6326510
Bi-aromatic compounds, compositions containing them and uses
expired patentUS 6326466
Double-stranded RNA dependent protein kinase derived peptides to promote proliferation of
expired patentUS 6326394
Calixarene tubes as cation receptors
expired patentUS 6326387
Methods and compositions for stimulating neurite growth
expired patentUS 6322780
Marek's disease virus vaccines for protection against Marek's disease
expired patentUS 6323225
Pharmaceutical composition
expired patentUS 6323201
Compounds for inhibition of ceramide-mediated signal transduction
expired patentUS 6323020
Neutralization-sensitive epitopes of Cryptosporidium parvum
expired patentUS 6320074
Compounds having selective activity for retinoid X receptors, and means for modulation of
expired patentUS 6319912
Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides
expired patentUS 6319495
Method for restoring glucose responsiveness to insulin secretion
expired patentUS 6319496
Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and
expired patentUS 6319687
Pigment epithelium-derived factor: characterization, genomic organization and sequence of
expired patentUS 6319691
Fusion proteins comprising IFN-alpha2b and TM-alpha1
expired patentUS 6319900
Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs
expired patentUS 6319904
Formulation comprising antibacterial substance and antiulcer substance
expired patentUS 6316504
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
expired